Medical specialists from France tagged as investigators in clinical trials studying Long QT Syndrome 1

Total 9 results

Dominique BABUTY, PU-PH
Seen in:
- Tours, Chu Tours
Trials:
- NCT01745666 (Principal Investigator)
Conditions:
- Long QT Syndrome Type 1 or 2
Eric PEYROUSE, PH
Seen in:
- Marseille, Marseille Universitary Hospital
Trials:
- NCT01745666 (Principal Investigator)
Conditions:
- Long QT Syndrome Type 1 or 2
Frederic ANSELME, PH
Seen in:
- Rouen, CHU Rouen
Trials:
- NCT01745666 (Principal Investigator)
Conditions:
- Long QT Syndrome Type 1 or 2
Frederic SACHER, PH
Seen in:
- Bordeaux, Bordeaux Universitary Hospital
Trials:
- NCT01745666 (Principal Investigator)
Conditions:
- Long QT Syndrome Type 1 or 2
Jean-Claude DEHARO, PU-PH
Seen in:
- Marseille, Marseille Universitary Hospital
Trials:
- NCT01745666 (Principal Investigator)
Conditions:
- Long QT Syndrome Type 1 or 2
Jean-Luc PASQUIE, PH
Seen in:
- Montpellier, CHU Montpellier
Trials:
- NCT01745666 (Principal Investigator)
Conditions:
- Long QT Syndrome Type 1 or 2
Philippe MABO, PU-PH
Seen in:
- Rennes, Rennes Universitary Hospital
Trials:
- NCT01745666 (Principal Investigator)
Conditions:
- Long QT Syndrome Type 1 or 2
Philippe MAURY, PH
Seen in:
- Toulouse, CHU Toulouse
Trials:
- NCT01745666 (Principal Investigator)
Conditions:
- Long QT Syndrome Type 1 or 2
Vincent PROBST, PU-PH
Seen in:
- Nantes, Nantes Universitary Hospital
Trials:
- NCT01745666 (Principal Investigator)
Conditions:
- Long QT Syndrome Type 1 or 2

Clinical Trials on Long QT Syndrome 1

Nantes University Hospital

Unknown

Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients (QT long)

Long QT Syndrome Type 1 or 2

France
Herlev and Gentofte Hospital

Completed

Exploring Mechanisms and Morphology of QT Interval Prolongation (TriQarr)

Sudden Cardiac Death | Long Qt Syndrome 1-2

Denmark
Gilead Sciences

Completed

Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome

LQT2 Syndrome

United States
Gilead Sciences

Terminated

Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3

Long QT Syndrome Type 3

United States, Germany, Canada, Netherlands, Italy, France, Israel, United Kingdom
Tel-Aviv Sourasky Medical Center

Unknown

Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine

Long QT Syndrome Type 3

Israel
Massachusetts General Hospital
Boston University; Mayo Clinic; Beth Israel Deaconess Medical Center; The Cleveland... and other collaborators

Terminated

A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes (BA-TdP)

Long qt Syndrome | Torsade de Pointes

United States
University Hospital, Montpellier
Institut National de la Santé Et de la Recherche Médicale, France

Active, not recruiting

Cardiac Rehabilitation of Children and Adolescent With Long QT Syndrome (RYTHMO'FIT)

Pediatric ALL | Long QT Syndrome | Inherited Cardiac Conduction Disorder | Congenital Long Qt Syndrome

France
KU Leuven
Agentschap voor Innovatie door Wetenschap en Technologie

Completed

QT-prolongation in Psychiatric Hospitals

QT-prolongation

Belgium
KU Leuven
Agentschap voor Innovatie door Wetenschap en Technologie

Completed

Drug Interactions With Risk of QT-prolongation in a General Hospital

QT-prolongation

Belgium
NorthShore University HealthSystem

Unknown

Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery

EKG-QT Prolongation

United States

Medical specialists from France tagged as investigators in clinical trials studying Long QT Syndrome 1

Clinical Trials on Long QT Syndrome 1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations